Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

Commercialisation of neuronal cell co-cultures

Descripción del proyecto

Ensayos con neuronas listos para su uso en pruebas farmacológicas

Las células madre pluripotentes inducidas se obtienen mediante la reprogramación de células somáticas adultas con factores de pluripotencia específicos. Son una herramienta potente para modelizar enfermedades humanas y producir tipos de células raras o difíciles de cultivar. El equipo del proyecto COMMER-CELL, financiado con fondos europeos, capitaliza los resultados del proyecto FETOPEN MESO-BRAIN para desarrollar y comercializar cocultivos neuronales en dos y tres dimensiones. Estos cocultivos pueden mantener la funcionalidad neuronal y servir como modelos para la enfermedad de Alzheimer. El objetivo del proyecto COMMER-CELL es suministrar estos modelos de células para pruebas farmacológicas, así como para la investigación de enfermedades del sistema nervioso central.

Objetivo

Development of various human stem cell derived cell types will be carried out to see the completion of the FETOPEN MESO-BRAIN project. Based on immortal pluripotent stem cells (iPSCs), FETOPEN MESO-BRAIN will see the development of techniques for growth of a variety of neural cell types. This provides a unique opportunity for the creation of a marketable product stemming from already intended work. Co-cultured in vitro cell models have the capacity to retain neuronal maturity and functionality for long time periods. Such co-cultures, featuring only two or three different cell types have already been demonstrated as effective models for researching the mechanisms of conditions such as Alzheimer’s disease, indicating consistent and reproducible results. As such, complex and consistently reproducible ready-made co-cultures could be easily directed towards pharmaceutical and biotech companies seeking to use iPSC-derived cells as a basis for building cell-based assays and drug screening based on the validated cells.
As the FETOPEN MESO-BRAIN project already intends to grow major neuronal cell types, complex, physiologically relevant 2D and 3D co-cultures featuring cortical neurones, astrocytes, interneurons and microglia can be developed within COMMER-CELL and made available for sale. Creation and mass-availability of a 4-cell-type co-culture in an easy-to-use and premade form could not only allow for improved research into CNS-affecting conditions and drug testing, but also expedite such research by circumventing the need for research institutions and industrial organisation to create their own time-consuming cell models.
The proposed COMMER-CELL project harnesses results from MESO-BRAIN to deliver concrete added value by raising the technological maturity of the cells to demonstrator level. The fulfilment of the proposition, based upon anticipated positive feedback from the market, will lead to the commercialisation of an innovation derived from FETOPEN MESO-BRAIN.

Ámbito científico (EuroSciVoc)

Programa(s)

Tema(s)

Régimen de financiación

CSA - Coordination and support action

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) H2020-FETOPEN-2018-2020

Ver todos los proyectos financiados en el marco de esta convocatoria

Coordinador

AXOL BIOSCIENCE LTD
Aportación neta de la UEn
€ 100 000,00
Dirección
SUITE 3 THE SCIENCE VILLAGE CHESTERFORD RESEARCH P
CB10 1XL Cambridge
Reino Unido
Región
East of England Essex West Essex
Tipo de actividad
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Enlaces
Coste total
€ 100 000,00